Prominex

About:

Prominex is focused on the development and manufacture of molecular diagnostic assays for Point-of-Care (POC) infectious disease testing.

Website: https://prominex.com/

Top Investors: Casdin Capital, Paul G. Thomas

Description:

Prominex is moving forward with ambitions to develop a 5-minute SARS-CoV-2 test on their point-of-care molecular diagnostic platform. The company is dedicated to increasing access to low-cost, quick infectious disease diagnostics for STIs and respiratory illnesses. Our SARS-CoV-2 test provides accurate results in 5 minutes, allowing healthcare practitioners to make more informed treatment and infection management decisions. devoted to increasing access to low-cost, quick infectious disease tests for STIs and respiratory illnesses. Our SARS-CoV-2 test provides accurate results in 5 minutes, allowing healthcare practitioners to make more informed treatment and infection management decisions.